查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771630

美國顯影劑市場規模、佔有率、趨勢分析報告（按產品、最終用途、類型、細分市場預測，2025-2030 年）

U.S. Contrast Media Injectors Market Size, Share & Trends Analysis Report By Product (Injector Systems, Consumables), By Application (Radiology, Interventional Cardiology), By Type, By End Use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

美國顯影劑注射器市場的趨勢：

預計 2024 年美國顯影劑注射器市場規模將達到 6.0494 億美元，2025 年至 2030 年的複合年成長率將達到 10.08%。

市場成長的動力來自於癌症、心血管疾病、神經系統疾病等慢性疾病的發生率上升。慢性疾病的增加推動了使用傳統影像方式（如 X 光和超音波）以及先進影像技術（如電腦斷層掃描和 MRI）進行診斷影像測試的需求。

受MRI、 電腦斷層掃描和血管造影術等診斷影像需求成長的推動，北美顯影劑注射器產業預計將經歷顯著成長。這種快速成長的驅動力源於影像技術的進步、人口老化、預防保健意識的增強以及慢性病的流行。醫學影像對於各種疾病的早期發現、診斷和治療計劃至關重要。根據美國國家醫學圖書館2023年10月發布的一項研究，美國每年約進行4000萬次MRI掃描。

此外，美國疾病管制與預防中心 (CDC) 於 2024 年 2 月發布的數據顯示，約有 1.29 億美國至少患有一種主要慢性疾病。如此沉重的慢性疾病負擔，加上每年進行的大量影像檢查，凸顯了對診斷影像學的強勁且不斷成長的需求，進一步推動了全部區域輸液設備顯影劑的需求。因此，長期疾病和複雜合併症的盛行率不斷上升是導致顯影劑注射器需求增加的主要促進因素之一。

預計顯影劑注射器產品上市和法規核准的不斷增加將顯著推動市場成長。各公司正在引進無針注射器和多劑量注射器等先進技術，以提高效率和病患治療效果。這些技術創新透過增強業務流程和支援更完善的診斷成像實踐，推動了先進診斷成像系統的廣泛應用。因此，對可靠有效的顯影劑輸送解決方案的需求持續成長，進一步推動了市場擴張。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國顯影劑注射器市場變數、趨勢與範圍

  • 市場展望
    • 相關/支持市場展望
  • 使用者觀點分析
    • 消費行為分析
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國顯影劑注射器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國顯影劑注射器市場：產品評估與趨勢分析

  • 定義和範圍
  • 2018年及2030年產品市場佔有率
  • 細分儀表板
  • 美國造影劑顯影劑市場：產品展望
  • 2024年至2030年市場規模、預測與趨勢分析
    • 噴射系統
    • 耗材

第5章美國顯影劑注射器市場：類型評估與趨勢分析

  • 定義和範圍
  • 2018 年及 2030 年各類型市場佔有率
  • 細分儀表板
  • 美國造影劑顯影劑市場展望（按類型）
  • 2024年至2030年市場規模、預測與趨勢分析
    • 單頭注射器
    • 雙頭注射器
    • 無針注射器

第6章美國顯影劑注射器市場：應用評估與趨勢分析

  • 定義和範圍
  • 2018 年和 2030 年應用市場佔有率
  • 細分儀表板
  • 美國顯影劑注射器市場：應用前景
  • 2024年至2030年市場規模、預測與趨勢分析
    • 放射學
    • 介入性心臟病學
    • 介入放射學

第7章美國顯影劑注射器市場：最終用途估計與趨勢分析

  • 定義和範圍
  • 2018 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 美國顯影劑注射器市場：最終用途展望
  • 2024年至2030年市場規模、預測與趨勢分析
    • 醫院
    • 診斷中心
    • 門診手術中心

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • Key company market share analysis, 2024
    • Shenzhen Boon Medical Supply Co., Ltd.
    • Bracco Diagnostics Inc.
    • Bayer
    • Guerbet
    • ulrich GmbH &Co. KG
    • B.Braun SE
    • Shenzhen Antmed Co., Ltd.
    • Ecomed Solutions
    • Siemens Medical Solutions USA, Inc.（Siemens Healthineers AG）
Product Code: GVR-4-68040-231-5

U.S. Contrast Media Injectors Market Trends:

The U.S. contrast media injectors market size was estimated at USD 604.94 million in 2024 and is projected to grow at a CAGR of 10.08% from 2025 to 2030. The market growth is attributed to the rising incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders. The rising number of chronic diseases is driving the demand for diagnostic imaging tests that use conventional imaging methods such as X-rays and ultrasounds, along with advanced imaging techniques such as CT scans and MRIs.

The North America contrast media injectors industry is expected to grow significantly, driven by the rising demand for imaging procedures such as MRI, CT scans, and cardiovascular angiography. This surge is fueled by advancements in imaging technology, an aging population, increasing awareness of preventive healthcare, and the growing prevalence of chronic diseases. Medical imaging is critical in early detection, diagnosis, and treatment planning for a wide range of conditions. According to a study published by the National Library of Medicine in October 2023, nearly 40 million MRI scans are performed annually in the U.S.

In addition, data from the CDC in February 2024 revealed that approximately 129 million Americans are living with at least one major chronic illness. This substantial burden of chronic disease, combined with the high volume of imaging tests performed each year, highlights a strong and growing need for diagnostic imaging, further driving demand for contrast media injectors across the region. Hence, the increasing prevalence of long-term diseases and complex comorbidities is one of the major drivers, as it is leading to an increase in demand for contrast media injectors.

The growing number of product launches and regulatory approvals for contrast media injectors is expected to drive market growth significantly. Companies are introducing advanced technologies, including syringeless and multi-patient injectors, to improve efficiency and patient outcomes. These innovations enhance operational workflows and support better imaging practices, encouraging broader adoption of advanced imaging systems. As a result, the demand for reliable and effective contrast media delivery solutions continues to rise, further fueling market expansion.

U.S. Contrast Media Injectors Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. contrast media injectors market report based on product, type, application, and end use:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Injector Systems
    • CT injector systems
    • MRI injector systems
    • Cardiovascular/angiography injector systems
  • Consumables
    • Tubing
    • Syringe
    • Others
  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Single Head Injectors
  • Dual-Head Injectors
  • Syringeless Injectors
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Radiology
  • Interventional Cardiology
  • Interventional Radiology
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Diagnostics Centers
  • Ambulatory Surgery Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Third Party Perspective
    • 1.3.5. Primary research
    • 1.3.6. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights Outlook

Chapter 3. U.S. Contrast Media Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Related/ancillary market outlook.
  • 3.2. User Perspective Analysis
    • 3.2.1. Consumer behavior analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing demand for imaging tests
      • 3.3.1.2. Rising launches and approvals of contrast media injectors
      • 3.3.1.3. Increasing prevalence of chronic disorders
      • 3.3.1.4. Growing adoption of syringe less injectors
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Potential complications and risks associated with contrast media injections
    • 3.3.3. Market opportunity analysis
      • 3.3.3.1. Rising number of distribution agreements
      • 3.3.3.2. Advancements in contrast media injectors
      • 3.3.3.3. Growing clinical trials for contrast media and injectors
    • 3.3.4. Market challenge analysis
      • 3.3.4.1. Shortage of radiologists and healthcare professionals
  • 3.4. U.S. Contrast Media Injectors Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. U.S. Contrast Media Injectors Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. U.S. Contrast Media Injectors Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 4.5.1. Injector Systems
      • 4.5.1.1. Injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.2. CT injector systems
        • 4.5.1.2.1. CT injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.3. MRI injector systems
        • 4.5.1.3.1. MRI injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.4. Cardiovascular/angiography injector systems
        • 4.5.1.4.1. Cardiovascular/angiography injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Consumables
      • 4.5.2.1. Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.2. Syringes
        • 4.5.2.2.1. Syringes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.3. Tubings
        • 4.5.2.3.1. Tubings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.4. Others
        • 4.5.2.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Contrast Media Injectors Market: Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Type Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. U.S. Contrast Media Injectors Market by Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 5.5.1. Single Head Injectors
      • 5.5.1.1. Single head injectors market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Dual Head Injectors
      • 5.5.2.1. Dual head injectors market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Syringeless Injectors
      • 5.5.3.1. Syringeless injectors market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. Contrast Media Injectors Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Application Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. U.S. Contrast Media Injectors Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 6.5.1. Radiology
      • 6.5.1.1. Radiology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Interventional Cardiology
      • 6.5.2.1. Interventional cardiology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Interventional Radiology
      • 6.5.3.1. Interventional radiology market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. Contrast Media Injectors Market: End Use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. End Use Market Share, 2018 & 2030
  • 7.3. Segment Dashboard
  • 7.4. U.S. Contrast Media Injectors Market by End Use Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 7.5.1. Hospitals
      • 7.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Diagnostics Centers
      • 7.5.2.1. Diagnostics centers market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Ambulatory Surgery Centers
      • 7.5.3.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Shenzhen Boon Medical Supply Co., Ltd.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bracco Diagnostics Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bayer
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Guerbet
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. ulrich GmbH & Co. KG
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. B.Braun SE
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Shenzhen Antmed Co., Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Ecomed Solutions
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Siemens Medical Solutions USA, Inc. (Siemens Healthineers AG)
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. contrast media injectors market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. contrast media injectors market, by type, 2018 - 2030 (USD Million)
  • Table 5 U.S. contrast media injectors market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. contrast media injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Contrast media injectors market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's Five Forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 U.S. Contrast media injectors market: Product movement analysis
  • Fig. 19 U.S. Contrast media injectors market: Product Segment dashboard
  • Fig. 20 U.S. Contrast media injectors market product outlook: Key takeaways
  • Fig. 21 U.S. Injector systems market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. CT injector systems market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. MRI injector systems market, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Cardiovascular/angiography injector systems market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Consumables market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Syringes market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Tubings market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Contrast media injectors market: Type movement analysis
  • Fig. 30 U.S. Contrast media injectors market: Type Segment dashboard
  • Fig. 31 U.S. Contrast media injectors market type outlook: Key takeaways
  • Fig. 32 U.S. Single head injectors market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Dual head injectors market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Syringeless injectors market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Contrast media injectors market: Application movement analysis
  • Fig. 36 U.S. Contrast media injectors market: Application Segment dashboard
  • Fig. 37 U.S. Contrast media injectors market application outlook: Key takeaways
  • Fig. 38 U.S. Radiology market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Interventional cardiology market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Interventional radiology market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Contrast media injectors market: End use movement analysis
  • Fig. 42 U.S. Contrast media injectors market: End use Segment dashboard
  • Fig. 43 U.S. Contrast media injectors market end use outlook: Key takeaways
  • Fig. 44 U.S. Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Diagnostics centres market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Ambulatory surgery centers market, 2018 - 2030 (USD Million)
  • Fig. 47 Company market share analysis, 2024
  • Fig. 48 Market differentiators